"Debridement PhagE AnTibiotics for PJI"

NCT07698002 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Periprosthetic Infection

Interventions

BIOLOGICAL: The investigational product specifically targeting P. aeruginosa (DP-QB-PSA-005) and that targeting S. aureus (DP-QB-STA-005), each formed of a mixture of 5 bacteriophages.

Sponsor

Ottawa Hospital Research Institute